NEOGENOMICS INC — Director's Dealing 2020

Jun 4, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2020-05-28

Reporting Person: Stahler Rachel A (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-05-28	Common Stock	A	2698	—	Acquired	2698	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-05-28	Stock Option (Right to Buy)	$28.54	A	3448	Acquired	2027-05-28	Common Stock (3448.0)	Direct